We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Shire Sues Nostrum Pharma Over ANDA For Epilepsy Drug

Law360 (January 14, 2004, 12:00 AM EST) -- U.K. drug maker Shire Pharmaceuticals Group has sued Nostrum Pharmaceuticals over its plans to produce a generic version of Shire’s epilepsy drug Carbatrol.

The lawsuit was filed in the U.S. District Court for the District of New Jersey.

Patents on Carbatrol, an anti-convulsant that generated sales of $45 million in 2002, expire in 2011 and 2019.

Shire made total drug sales of $859 million in 2002.

The lawsuit results from an Abbreviated New Drug Application(ANDA) filed by Nostrum for a generic version of the 300 mg...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.